ClassID:

110961

C12N2760/18433 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Paramyxoviridae; Morbillivirus, e.g. Measles virus, canine distemper Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory

Recent Application in this class:
#1
20230279429
2023-09-07

DNA MOLECULES PRODUCING CUSTOM DESIGNED REPLICATING AND NON-REPLICATING NEGATIVE STRANDED RNA VIRUSES AND USES THERE OF

#2
20230272423
2023-08-31

DNA MOLECULES PRODUCING CUSTOM DESIGNED REPLICATING AND NON-REPLICATING NEGATIVE STRANDED RNA VIRUSES AND USES THERE OF

#3
20220396625
2022-12-15

TARGETING PD-L1 ON TUMOR CELLS

#4
20220125901
2022-04-28

TREATMENT OF CANCER USING RECALL ANTIGENS DELIVERED BY ATTENUATED BACTERIA

#5
20220112501
2022-04-14

Engineered immunostimulatory bacterial strains and uses thereof

#6
20210252085
2021-08-19

RNA viruses for immunovirotherapy

#7
20200071702
2020-03-05

Engineered immunostimulatory bacterial strains and uses thereof

#8
20190292229
2019-09-26

Method for producing self-assembling paramyxoviral nucleocapsid-like particles and their uses

#9
20190211355
2019-07-11

DNA molecules producing custom designed replicating and non-replicating negative stranded RNA viruses and uses there of

#10
20190169296
2019-06-06

Targeting PD-L1 on tumor cells

#11
20180104320
2018-04-19

Treatment of cancer using recall antigens delivered by attenuated bacteria

#12
20170340726
2017-11-30

Gene-modified measles virus for tumor treatment use

#13
20170158741
2017-06-08

Peptides including a binding domain of the viral phosphoprotein (P) subunit to the viral RNA free nucleoprotein (N)

#14
20170065650
2017-03-09

RNA viruses for immunovirotherapy

#15
20150239940
2015-08-27

Compositions and methods for measles virus inhibition

#16
20120289458
2012-11-15

Treatment of influenza virus infection

#17
20090264362
2009-10-22

Influenza virus inhibiting peptides

#18
20060280754
2006-12-14

Influenza virus inhibiting peptides